Skip to main content
. 2007 Feb 12;64(1):83–89. doi: 10.1111/j.1365-2125.2007.02851.x

Table 2.

Precipitation of reflux-related symptoms during calcium antagonist (CA) therapy

Precipitation of reflux-related symptoms
CA n Total % P-value
Nifedipine 23 51 36.5 0.043
Amlodipine 19 50 35.8 0.005
Felodipine 17 45 32.0 0.118
Verapamil 18 45 39.1 0.001
Diltiazem  8 24 30.7 0.107
Total 85 215 35.3
HHS Vulnerability Disclosure